News

In addition to the recently issued US patents, the company was granted: AU 2004241093, corresponding to US Patent No 7,569,554, entitled ‘Synergistic Treatment of Cancer Using Immunomers in

Pfizer said that the expansion of Singapore Nutrition Plant increases the production capacity by 50% thereby increasing the plants’s ability to supply nutrition products to Singapore and other

eClinicalWorks has received grant of $598m from the national REC program to establish 60 centers which is expected to bring together relation healthcare organizations, community health centers and

An autologous cell therapy, azficel-T is currently under review by the FDA for the treatment of moderate to severe nasolabial fold wrinkles. The histology study was requested by

Standard Process said that ProSynbiotic is a mix of four research-supported probiotic strains and two prebiotic fibers, designed to support gut flora and overall intestinal health. Standard Process

Meridian said that Liaison is a fully automated, random access system based on chemiluminescense detection. The agreement is royalty-based with the actual royalty amount to be paid to

FDA has also prompted the manufacturer to develop a risk management plan aimed at educating health care professionals and patients about the potential risks. The risk management plan,

The commercial and external partnership within industrial affairs (CEPiA) is managing the MSA at Sanofi-avantis, which will allow Oramed Pharma to leverage sanofi-aventis’ ability and expertise regarding quality

WSBI is currently advancing its lead molecule, WSBI-711, which is an antibody against two TCISM targets into midstage pre-clinical testing. WSBI’s other TCISM antibody and orally-active small molecule